A GLP‐1/GLP‐2 receptor dual agonist to treat NASH : Targeting the gut‐liver axis and microbiome
出版年份 2021 全文链接
标题
A
GLP‐1/GLP‐2
receptor dual agonist to treat
NASH
: Targeting the gut‐liver axis and microbiome
作者
关键词
-
出版物
HEPATOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-11-13
DOI
10.1002/hep.32235
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapeutic pipeline in nonalcoholic steatohepatitis
- (2021) Raj Vuppalanchi et al. Nature Reviews Gastroenterology & Hepatology
- Pharmacological activation of TGR5 promotes intestinal growth via a GLP-2-dependent pathway in mice
- (2020) Jenna Elizabeth Hunt et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- FXR Agonists as Therapy for Liver Disease
- (2020) Jay H. Hoofnagle HEPATOLOGY
- Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease
- (2019) Shun He et al. NATURE
- Differential Action of TGR5 Agonists on GLP-2 Secretion and Promotion of Intestinal Adaptation in Piglet Short Bowel Model
- (2019) Sen Lin et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations from the Liver Forum
- (2019) Amanda Cheung et al. HEPATOLOGY
- Epidemiology of chronic liver diseases in the USA in the past three decades
- (2019) Zobair M Younossi et al. GUT
- Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
- (2019) Clara Depommier et al. NATURE MEDICINE
- Interplay between the human gut microbiome and host metabolism
- (2019) Alessia Visconti et al. Nature Communications
- Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives
- (2019) Haiming Hu et al. JOURNAL OF GASTROENTEROLOGY
- Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!
- (2019) Golnaz Ranjbar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis
- (2018) Teresa García-Lezana et al. HEPATOLOGY
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice
- (2018) Pernille Wismann et al. PHYSIOLOGY & BEHAVIOR
- Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
- (2018) Christoph A. Thaiss et al. SCIENCE
- Burden of Illness and Economic Model for Patients with Non-Alcoholic Steatohepatitis (NASH) in the United States
- (2018) Zobair M. Younossi et al. HEPATOLOGY
- Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice
- (2018) Zi-Lun Lai et al. Scientific Reports
- The role of the microbiome in NAFLD and NASH
- (2018) Aleksandra A Kolodziejczyk et al. EMBO Molecular Medicine
- Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease
- (2017) Feng Shen et al. Hepatobiliary & Pancreatic Diseases International
- Bile acids in nonalcoholic steatohepatitis: Pathophysiological driving force or innocent bystanders?
- (2017) Daniel Jahn et al. HEPATOLOGY
- Glucagon-like peptide-2 promotes gallbladder refilling via a TGR5-independent, GLP-2R-dependent pathway
- (2017) Bernardo Yusta et al. Molecular Metabolism
- Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases
- (2017) Eugene Han et al. Diabetes & Metabolism Journal
- Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota
- (2017) Da Zhou et al. Scientific Reports
- The Colonic Crypt Protects Stem Cells from Microbiota-Derived Metabolites
- (2016) Gerard E. Kaiko et al. CELL
- Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models
- (2016) Mitsuaki Ishioka et al. DIGESTIVE DISEASES AND SCIENCES
- Pathogenesis of Nonalcoholic Steatohepatitis
- (2016) Mariana Verdelho Machado et al. GASTROENTEROLOGY
- Effect of 12-week dulaglutide therapy in Japanese patients with biopsy-proven non-alcoholic fatty liver disease and type 2 diabetes mellitus
- (2016) Yuya Seko et al. HEPATOLOGY RESEARCH
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism
- (2016) Renee L. Greer et al. Nature Communications
- GLP-1R Agonists Promote Normal and Neoplastic Intestinal Growth through Mechanisms Requiring Fgf7
- (2015) Jacqueline A. Koehler et al. Cell Metabolism
- Dietary Fiber-Induced Improvement in Glucose Metabolism Is Associated with Increased Abundance of Prevotella
- (2015) Petia Kovatcheva-Datchary et al. Cell Metabolism
- GLP-1R Agonists Modulate Enteric Immune Responses Through the Intestinal Intraepithelial Lymphocyte GLP-1R
- (2015) Bernardo Yusta et al. DIABETES
- Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time
- (2015) Cathrin Sellmann et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Another Agent for Obesity — Will This Time Be Different?
- (2015) Elias S. Siraj et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease
- (2015) Weiwei Jiang et al. Scientific Reports
- Changes in Gut Microbiota in Rats Fed a High Fat Diet Correlate with Obesity-Associated Metabolic Parameters
- (2015) Virginie Lecomte et al. PLoS One
- Glugacon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration
- (2014) Noura El-Jamal et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent
- (2013) Laura Wrzosek et al. BMC BIOLOGY
- Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet
- (2013) Sara Baldassano et al. JOURNAL OF ENDOCRINOLOGY
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- Deficiency in Interferon-γ Results in Reduced Body Weight and Better Glucose Tolerance in Mice
- (2011) Nicole Wong et al. ENDOCRINOLOGY
- Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway
- (2010) Nitika Arora Gupta et al. HEPATOLOGY
- Fibrogenic signalling in hepatic stellate cells
- (2010) Derek A. Mann et al. JOURNAL OF HEPATOLOGY
- QIIME allows analysis of high-throughput community sequencing data
- (2010) J Gregory Caporaso et al. NATURE METHODS
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
- (2009) Luca Miele et al. HEPATOLOGY
- Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2
- (2008) Catherine P. A. Ivory et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search